Loading
Health workers with a torch and vinegar, screening women in Mumbai's slums every two years, cut cervical cancer deaths by 31% in a trial of more than 150,000 women.
75,360 women in ten screening clusters and 76,178 in ten control clusters were enrolled; screening participation was 89% and compliance with diagnostic confirmation 79.4%. Invasive cervical cancer incidence was similar (26.74 versus 27.49 per 100,000) but cervical cancer mortality fell by 31% (rate ratio 0.69; 95% CI 0.54-0.88; P=0.003), with better treatment completion in the screened group (86.3% versus 72.3%). The authors estimated that this approach could prevent about 22,000 cervical cancer deaths a year in India. Together with Osmanabad it shaped India's operational guidelines for population screening where HPV testing is not yet affordable.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
Shares Surendra Shastri, Osmanabad cervical screening trial (HPV testing vs cytology vs VIA), HPV DNA testing and self-sampling, Tata Memorial Centre.
Shares Colposcopy and excisional treatment (LEEP/LLETZ, cone), HPV DNA testing and self-sampling, The hardest cancers are found late, Cervical cancer.
Shares Visual inspection with acetic acid (VIA) for cervical screening, Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation, Most of the world has almost no cancer care, Cervical cancer.
Shares Colposcopy and excisional treatment (LEEP/LLETZ, cone), Visual inspection with acetic acid (VIA) for cervical screening, HPV DNA testing and self-sampling, Cervical cancer.
Shares Tata Memorial Centre, Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation, Most of the world has almost no cancer care, Cervical cancer.
Shares Tata Memorial Centre, Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation, Most of the world has almost no cancer care, Cervical cancer.
Shares Not enough oncologists, nurses, pathologists, physicists, Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation, Most of the world has almost no cancer care, Cervical cancer.
Shares Visual inspection with acetic acid (VIA) for cervical screening, Most of the world has almost no cancer care, Cervical cancer.